---
title: "NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C. | VNDA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296687031.md"
description: "Vanda Pharmaceuticals Inc. announced that its NEREUS™ branded No. 47 IndyCar, driven by Mick Schumacher for Rahal Letterman Lanigan Racing, will compete in the inaugural Freedom 250 Grand Prix on Washington D.C.'s National Mall on August 22-23, 2026. This event celebrates America's 250th anniversary. NEREUS™, a prescription medication for motion-induced vomiting, is the primary sponsor, aligning with Vanda's focus on performance and stability."
datetime: "2026-08-22T11:16:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296687031.md)
  - [en](https://longbridge.com/en/news/296687031.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296687031.md)
generator: "portal-rs"
---

# NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C. | VNDA Stock News

, /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the NEREUS™ branded No. 47 entry from Rahal Letterman Lanigan Racing, driven by Mick Schumacher, is set to compete this weekend in the inaugural Freedom 250 Grand Prix of Washington, D.C., the first-ever NTT INDYCAR SERIES race on the National Mall.

The event, taking place August 22–23, 2026, celebrates America's 250th anniversary with high-speed racing on a 1.7-mile, seven-turn temporary street circuit framed by the Washington Monument, U.S. Capitol, and other iconic landmarks. Practice and qualifying occur Saturday, with the 147-lap, approximately 250-mile race scheduled for Sunday afternoon and broadcast live on FOX.

NEREUS™ (tradipitant), the first new U.S. prescription medication approved for the prevention of motion-induced vomiting in 47 years, is the primary sponsor of the No. 47 Honda. The partnership, announced by Vanda, aligns the brand's focus on performance and stability with the demands of IndyCar racing. This weekend marks a home event for the Washington-based company.

"Partnering with the No. 47 car perfectly captures this historic moment and our shared commitment to performance under challenging conditions," said Mihael H. Polymeropoulos, M.D., President, CEO and Chairman of the Board of Vanda.

Fans can follow the No. 47 NEREUS™ IndyCar as Schumacher and Rahal Letterman Lanigan Racing take on this landmark street circuit in the nation's capital.

**About NEREUS™ (tradipitant)**

NEREUS™ is an oral NK-1 receptor antagonist FDA-approved for the prevention of vomiting induced by motion in adults. It is the first new pharmacologic treatment approved for this indication in over four decades.

**About Vanda Pharmaceuticals Inc.**

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com and follow us on X @vandapharma.

**About Rahal Letterman Lanigan Racing**

Rahal Letterman Lanigan Racing is a championship-winning team competing in the NTT IndyCar Series.

**Corporate Contact:**

Kevin Moran  
Senior Vice President, Chief Financial Officer and Treasurer  
Vanda Pharmaceuticals Inc.  
202-734-3400  
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore  
Collected Strategies  
VANDA-CS@collectedstrategies.com

SOURCE Vanda Pharmaceuticals Inc.

### Related Stocks

- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)

## Related News & Research

- [Vanda says EU grants orphan drug status to imsidolimab for generalized pustular psoriasis](https://longbridge.com/en/news/296776870.md)
- [New Model Home Now Open at Toll Brothers at Quail Ridge in Ridgefield, Washington | TOL Stock News](https://longbridge.com/en/news/296510337.md)
- [Century Communities Announces Grand Opening of New Home Phase at Uplands in Puyallup, Washington | CCS Stock News](https://longbridge.com/en/news/296522285.md)
- [Freedom Holding Marks New Türkiye Milestone as Freedom Yatırım Secures Brokerage License | FRHC Stock News](https://longbridge.com/en/news/296302717.md)
- [LibertyStream Reports Three Months of Consistent Battery-Grade Lithium Carbonate Production | VLTLF Stock News](https://longbridge.com/en/news/296791086.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**